XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Employee Benefit Plans (Tables)
6 Months Ended
Dec. 31, 2022
Share Based Compensation [Abstract]  
Common Stock Reserved for Future Issuance

The Company had the following reserved shares of common stock for future issuance as of the dates noted (in thousands):

 

 

December 31,

2022

 

 

June 30,

2022

 

2013 Equity Incentive Plan shares available for grant

 

 

9,764

 

 

 

11,430

 

Employee stock options and awards outstanding

 

 

10,830

 

 

 

7,616

 

2014 Employee Stock Purchase Plan

 

 

9,280

 

 

 

9,961

 

Total shares reserved for issuance

 

 

29,874

 

 

 

29,007

 

Schedule of Recognized Share-based Compensation Expense

Share-based compensation expense recognized in the condensed consolidated financial statements by line-item caption is as follows (in thousands):

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

December 31,

2022

 

 

December 31,

2021

 

 

December 31,

2022

 

 

December 31,

2021

 

Cost of product revenues

 

$

499

 

 

$

303

 

 

$

873

 

 

$

613

 

Cost of service and subscription revenues

 

 

966

 

 

 

351

 

 

 

1,638

 

 

 

713

 

Research and development

 

 

3,962

 

 

 

2,664

 

 

 

7,052

 

 

 

5,122

 

Sales and marketing

 

 

5,910

 

 

 

3,860

 

 

 

10,549

 

 

 

7,435

 

General and administrative

 

 

6,059

 

 

 

4,155

 

 

 

11,073

 

 

 

7,894

 

Total share-based compensation expense

 

$

17,396

 

 

$

11,333

 

 

$

31,185

 

 

$

21,777

 

Summary of Stock Option Activity

The following table summarizes stock option activity for the six months ended December 31, 2022 (in thousands, except per share and contractual term):

 

 

 

Number of Shares

 

 

Weighted-Average Exercise Price Per Share

 

 

Weighted-Average Remaining Contractual Term (years)

 

 

Aggregate Intrinsic Value

 

Options outstanding at June 30, 2022

 

 

1,187

 

 

$

6.56

 

 

 

3.70

 

 

$

2,801

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Canceled

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options outstanding at December 31, 2022

 

 

1,187

 

 

$

6.56

 

 

 

3.20

 

 

$

13,948

 

Vested and expected to vest at December 31, 2022

 

 

1,187

 

 

$

6.56

 

 

 

3.20

 

 

$

13,948

 

Exercisable at December 31, 2022

 

 

1,068

 

 

$

6.55

 

 

 

3.14

 

 

$

12,562

 

Summary of Stock Award Activity

The following table summarizes stock award activity for the six months ended December 31, 2022 (in thousands, except grant date fair value):

 

 

 

Number of Shares

 

 

Weighted- Average Grant Date Fair Value

 

 

Aggregate Fair Value

 

Non-vested stock awards outstanding at June 30, 2022

 

 

6,429

 

 

$

9.57

 

 

 

 

 

Granted

 

 

6,186

 

 

 

14.50

 

 

 

 

 

Released

 

 

(2,731

)

 

 

8.30

 

 

 

 

 

Canceled

 

 

(241

)

 

 

11.31

 

 

 

 

 

Non-vested stock awards outstanding at December 31, 2022

 

 

9,643

 

 

$

13.05

 

 

$

176,564

 

Stock awards expected to vest at December 31, 2022

 

 

9,643

 

 

$

13.05

 

 

$

176,564

 

Schedule of Awards Performance Thresholds and Shares Expected to Vest (TSR PSUs) The MSU award represents the right to receive a target number of shares of common stock of up to 150% of the original grant, as indicated in the table below. The MSUs vest based on the Company’s TSR relative to the TSR of the Index over performance periods of three years from the grant date, subject to the grantees’ continued service through the certification of performance.

Level

Relative TSR

Shares Vested

 

Below Threshold

TSR is less than the Index by more than 37.5 percentage points

0%

 

Threshold

TSR is less than the Index by 37.5 percentage points

25%

 

Target

TSR equals the Index

100%

 

Maximum

TSR is greater than the Index by 25 percentage points or more

150%

 

 

Schedule of Fair Value Assumptions for Employee Stock Purchase Plan Awards The following assumptions were used to determine the grant-date fair values of the ESPP shares during the following periods:

 

 

 

Employee Stock Purchase Plan

 

 

 

Three Months Ended

 

 

 

December 31,

2022

 

 

December 31,

2021

 

Expected life

 

0.5 years

 

 

0.5 years

 

Risk-free interest rate

 

 

3.12

%

 

 

0.05

%

Volatility

 

 

60

%

 

 

52

%

Dividend yield

 

 

%

 

 

%